Strongbridge Biopharma plc
SBBP · NASDAQ
6/30/2021 | 3/31/2021 | 12/31/2020 | 9/30/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$13 | -$12 | -$12 | -$3 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2 | $2 | $2 | $2 |
| Change in WC | $0 | -$6 | $3 | $21 |
| Other Non-Cash | -$0 | $1 | $1 | -$27 |
| Operating Cash Flow | -$10 | -$13 | -$5 | -$6 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | $0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$0 | $0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $1 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | -$0 | $11 | $28 |
| Financing Cash Flow | -$0 | -$0 | $11 | $28 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$10 | -$14 | $6 | $22 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $74 | $88 | $82 | $60 |
| End Cash | $64 | $74 | $88 | $82 |
| Free Cash Flow | -$10 | -$13 | -$5 | -$6 |